These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30618524)

  • 21. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Abbott F; Tron V
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited efficacy of diphenylcyclopropenone in the treatment of alopecia areata: Experience from a Tertiary Healthcare Institution in Singapore.
    Leong WMS; Mok ZR; Chandran NS
    Dermatol Ther; 2020 Nov; 33(6):e14447. PubMed ID: 33098604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study.
    Thuangtong R; Suvansuthi S; Maneeprasopchoke P; Sukakul T; Techakajornkeart R; Chaweekulrat P; Wongdama S; Triwongwaranat D
    Int J Trichology; 2022; 14(3):91-96. PubMed ID: 35755959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
    Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata.
    Gong Y; Luo L; Li L; He X; Lu W; Sha X; Mao Y
    Exp Dermatol; 2021 Feb; 30(2):278-283. PubMed ID: 33325128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata.
    Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical immunotherapy treatment of alopecia areata with diphenylcyclopropenone: Regulatory T cells as biomarkers for treatment response.
    Kyrmanidou E; Apalla Z; Koletsa T; Sotiriou E; Ioannides D; Fotiadou C; Chatzopoulos S; Kemanetzi C; Lazaridou E
    Dermatol Ther; 2022 Jul; 35(7):e15522. PubMed ID: 35436374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical Immunotherapy of Alopecia Areata: A Large Retrospective Study.
    Zerbinati N; Esposito C; D'Este E; Calligaro A; Valsecchi R
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):101-110. PubMed ID: 29442292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Dermoscopic Evaluation in Predicting Clinical Response to Diphencyprone in a Cohort of Patients with Alopecia Areata.
    Abedini R; Alipour E; Ghandi N; Nasimi M
    Int J Trichology; 2020; 12(3):107-113. PubMed ID: 33223734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
    Chartaux E; Joly P
    Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical immunotherapy in alopecia areata.
    Singh G; Lavanya M
    Int J Trichology; 2010 Jan; 2(1):36-9. PubMed ID: 21188022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata.
    Suchonwanit P; Kositkuljorn C; Mahasaksiri T; Leerunyakul K
    J Dermatolog Treat; 2022 Mar; 33(2):756-761. PubMed ID: 32441159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment.
    Ganzetti G; Campanati A; Simonetti O; Cataldi I; Giuliodori K; Offidani AM
    Int J Immunopathol Pharmacol; 2011; 24(4):1087-91. PubMed ID: 22230416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Study of Efficacy and Safety of Topical Squaric Acid Dibutylester and Diphenylcyclopropenone for the Treatment of Alopecia Areata.
    Tiwary AK; Mishra DK; Chaudhary SS
    N Am J Med Sci; 2016 Jun; 8(6):237-42. PubMed ID: 27500127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients.
    Friedli A; Labarthe MP; Engelhardt E; Feldmann R; Salomon D; Saurat JH
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):597-602. PubMed ID: 9777767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.